Cameron Wilcox, MD
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician · Marquette, MI
Cameron Wilcox, MD is a diagnostic neuroimaging (psychiatry & neurology) physician with a practice address in Marquette, Michigan, and NPI 1386867711, issued on Apr 11, 2007. Check the license on the Michigan Board of Medicine; the Medicare figures below come from public CMS files.
- Name
- Cameron Wilcox
- Credential
- MD
- Primary taxonomy
- Diagnostic Neuroimaging (Psychiatry & Neurology) Physician 2084D0003X
- Practice location
- 200 W Spring St, Marquette, MI 49855
- Phone
- (906) 233-1236
- Enumerated
- Apr 11, 2007
- Entity
- Type 1 · individual
Also registered at 200 W Spring St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Rebecca AckleyCase Manager/Care Coordinator1134079650
- Amanda AndersonSocial Worker1255102448
- Amy Baranek, BCBABehavior Analyst1417337593
- Emily BarnesBehavior Technician1174014328
- Delaney Basala, LLBSWSocial Worker1215677620
- Deborah Bauman, LMSWClinical Social Worker1336387745
Verify Cameron Wilcox in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMichigan Board of MedicineCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
3.8 times the Medicare Part D claims of the average diagnostic neuroimaging (psychiatry & neurology) physician in 2024
3,836 Medicare Part D claims for 180 beneficiaries, against an average of 1,011 among the 21 providers of this specialty who prescribed in Part D. Brand-name drugs were 4% of claims.
Most prescribed
- Gabapentin268 claims
- Trazodone Hcl233 claims
- Quetiapine Fumarate231 claims
- Alprazolam175 claims
- Clonazepam169 claims
- Venlafaxine Hcl Er153 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
One hospital or facility affiliation
- Dlp Marquette Physician Practices IncMarquette, MI
Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician providers in Michigan
There are 1 diagnostic neuroimaging (psychiatry & neurology) physician records in Michigan.
Common questions
What is Cameron Wilcox, MD's NPI number?
Cameron Wilcox, MD's National Provider Identifier (NPI) is 1386867711, issued on Apr 11, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Cameron Wilcox, MD located?
The NPPES record lists a practice address at 200 W Spring St, Marquette, MI, 49855. Phone: (906) 233-1236. Providers update this record themselves, so call before visiting.
How can I verify Cameron Wilcox, MD's license?
Search the Michigan Board of Medicine at https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/medical. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Cameron Wilcox, MD prescribe under Medicare Part D?
In 2024, Cameron Wilcox, MD had 3,836 Medicare Part D claims for 180 beneficiaries; the average among diagnostic neuroimaging (psychiatry & neurology) physician prescribers was 1,011. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.